[KLK] QoQ TTM Result on 30-Jun-2012 [#3]

Announcement Date
29-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2012
Quarter
30-Jun-2012 [#3]
Profit Trend
QoQ- -13.78%
YoY- -12.11%
View:
Show?
TTM Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 9,579,314 9,967,968 10,570,188 11,150,218 11,499,296 11,243,449 10,743,252 -7.35%
PBT 1,423,799 1,450,841 1,560,436 1,686,915 1,944,900 2,137,131 2,066,205 -21.96%
Tax -254,352 -276,243 -300,347 -381,294 -425,191 -451,242 -420,674 -28.47%
NP 1,169,447 1,174,598 1,260,089 1,305,621 1,519,709 1,685,889 1,645,531 -20.34%
-
NP to SH 1,125,927 1,131,178 1,211,244 1,249,592 1,449,266 1,608,212 1,571,413 -19.91%
-
Tax Rate 17.86% 19.04% 19.25% 22.60% 21.86% 21.11% 20.36% -
Total Cost 8,409,867 8,793,370 9,310,099 9,844,597 9,979,587 9,557,560 9,097,721 -5.10%
-
Net Worth 7,188,518 7,454,759 7,113,970 6,783,831 7,007,474 7,348,263 7,071,622 1.09%
Dividend
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Div 692,227 692,227 692,227 905,247 905,247 905,269 905,269 -16.36%
Div Payout % 61.48% 61.20% 57.15% 72.44% 62.46% 56.29% 57.61% -
Equity
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Net Worth 7,188,518 7,454,759 7,113,970 6,783,831 7,007,474 7,348,263 7,071,622 1.09%
NOSH 1,064,965 1,064,965 1,064,965 1,064,965 1,064,965 1,064,965 1,065,003 -0.00%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin 12.21% 11.78% 11.92% 11.71% 13.22% 14.99% 15.32% -
ROE 15.66% 15.17% 17.03% 18.42% 20.68% 21.89% 22.22% -
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 899.50 935.99 992.54 1,047.00 1,079.78 1,055.76 1,008.75 -7.35%
EPS 105.72 106.22 113.74 117.34 136.09 151.01 147.55 -19.91%
DPS 65.00 65.00 65.00 85.00 85.00 85.00 85.00 -16.36%
NAPS 6.75 7.00 6.68 6.37 6.58 6.90 6.64 1.10%
Adjusted Per Share Value based on latest NOSH - 1,064,965
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 849.48 883.95 937.35 988.79 1,019.74 997.05 952.70 -7.35%
EPS 99.85 100.31 107.41 110.81 128.52 142.61 139.35 -19.90%
DPS 61.39 61.39 61.39 80.28 80.28 80.28 80.28 -16.36%
NAPS 6.3747 6.6108 6.3086 6.0158 6.2141 6.5163 6.271 1.09%
Price Multiplier on Financial Quarter End Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 -
Price 20.92 24.00 22.06 22.94 24.60 22.70 21.10 -
P/RPS 2.33 2.56 2.22 2.19 2.28 2.15 2.09 7.50%
P/EPS 19.79 22.60 19.40 19.55 18.08 15.03 14.30 24.16%
EY 5.05 4.43 5.16 5.11 5.53 6.65 6.99 -19.46%
DY 3.11 2.71 2.95 3.71 3.46 3.74 4.03 -15.85%
P/NAPS 3.10 3.43 3.30 3.60 3.74 3.29 3.18 -1.68%
Price Multiplier on Announcement Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 22/05/13 20/02/13 21/11/12 29/08/12 24/05/12 22/02/12 23/11/11 -
Price 21.70 21.32 20.56 23.24 22.16 23.64 21.38 -
P/RPS 2.41 2.28 2.07 2.22 2.05 2.24 2.12 8.91%
P/EPS 20.53 20.07 18.08 19.81 16.28 15.65 14.49 26.12%
EY 4.87 4.98 5.53 5.05 6.14 6.39 6.90 -20.71%
DY 3.00 3.05 3.16 3.66 3.84 3.60 3.98 -17.16%
P/NAPS 3.21 3.05 3.08 3.65 3.37 3.43 3.22 -0.20%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment